PipelinePharma Logo

butamirate citrate Syrup 0.15 %

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Jordan
GMP approvals
Jordan
Manufacturer #20744

​Established in 1994, this Manufacturer is a CTD dossier owner and manufacturer based in Amman, Jordan. With a workforce of approximately 234 employees, it operates GMP-certified facilities producing a diverse range of products, including tablets, capsules, syrups, creams, ointments, gels, suppositories, and shampoos. As a GMP manufacturer, it holds certifications adhering to international quality standards. The Manufacturer's products are distributed across over 12 countries and regions, primarily within the MENA region. Its commitment to excellence as a CTD dossier owner and manufacturer and GMP manufacturer solidifies its reputation in the global pharmaceutical market.​

BUTAMIRATE CITRATE Manufacturers and Suppliers

We have found 15 verified butamirate citrate manufacturers and butamirate citrate suppliers from our global list of sellers. The pharmaceutical drug is available for sale in different forms such as syrup, tablets from manufacturers in various countries including Turkey, European Union, Jordan, Bangladesh, Morocco.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of butamirate citrate offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for butamirate citrate manufacturers and butamirate citrate suppliers that you are looking for. These also enable you to check the dossier status of butamirate citrate, and the GMP approvals of the different variants of butamirate citrate. Also, each manufacturer or supplier product description contains essential information about butamirate citrate including clinical data, stability zones, countries where butamirate citrate is already registered in. Manufacturers also specify the commercial terms of their offers, such as the market for which the offer is intended, deal type, dossier licensing fee, supply price, payment terms, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over butamirate citrate offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that butamirate citrate manufacturers have, we qualify their companies before they are on-boarded on the platform. This allows us to screen butamirate citrate manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.